Admission of ordinary shares
Assura Group Limited ("Assura" or the "Company")
Admission of ordinary shares
Further to the Company's announcements of 17 and 18 February 2011, the Company confirms that it has made application for the admission to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities for 26,666,667 ordinary shares of 10p each pursuant to the firm placing announced on 19 January 2011.
It has also made application for the admission to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities for 39,853,587 ordinary shares of 10p each pursuant to the offer for AH Medical Properties plc which was declared unconditional as to acceptances on 18 February 2011. It is expected that these ordinary shares will be admitted to trading on 22 February 2011. Up to a further 2,031,672 ordinary shares of 10p each could be issued pursuant to the offer for AH Medical Properties plc. Following the admission of these new ordinary shares of 10p each the offer for AH Medical Properties plc will be wholly unconditional.
In accordance with DTR 5.6.1, the Company announces that following the admissions outlined above, the Company's issued share capital will consist of 409,384,653 ordinary shares of 10 pence each with voting rights. The Company currently holds no ordinary shares in treasury. Therefore, the total number of voting rights in the Company will be 409,384,653. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.
Enquiries:
|
Conor Daly (Company Secretary) |
020 7340 6301 |
|
|
|
|
Ben Atwell, Financial Dynamics |
020 7831 3113 |
This information is provided by RNS